BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29859520)

  • 1. [Activatable cell-penetrating peptides: a potential activatable modality for diseases diagnosis and therapy].
    Yang SK; Yan X; Sun WH; Du Q; Xiang B; Cao DY; Qi XR
    Yao Xue Xue Bao; 2016 Apr; 51(4):529-35. PubMed ID: 29859520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The application of enzyme-sensitive activatable cell-penetrating peptides to targeted delivery system].
    He F; Cao L; Zhang XJ; Xiang B; Cao DY; Qi XR
    Yao Xue Xue Bao; 2015 Feb; 50(2):141-7. PubMed ID: 25975019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of cell-penetrating peptides.
    Vasconcelos L; Pärn K; Langel U
    Ther Deliv; 2013 May; 4(5):573-91. PubMed ID: 23647276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in tumour-targeted drug delivery based on cell-penetrating peptides.
    Kong X; Xu J; Yang X; Zhai Y; Ji J; Zhai G
    J Drug Target; 2022 Jan; 30(1):46-60. PubMed ID: 33944641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents.
    MacEwan SR; Chilkoti A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(1):31-48. PubMed ID: 22977001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-penetrating peptides: possibilities and challenges for drug delivery in vitro and in vivo.
    Skotland T; Iversen TG; Torgersen ML; Sandvig K
    Molecules; 2015 Jul; 20(7):13313-23. PubMed ID: 26205056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-penetrating peptides as a novel transdermal drug delivery system.
    Nasrollahi SA; Taghibiglou C; Azizi E; Farboud ES
    Chem Biol Drug Des; 2012 Nov; 80(5):639-46. PubMed ID: 22846609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of activatable cell-penetrating peptide in the field of tumor therapy].
    Zhang L; Wei G; Lu WY
    Yao Xue Xue Bao; 2014 Dec; 49(12):1639-43. PubMed ID: 25920191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents.
    Borrelli A; Tornesello AL; Tornesello ML; Buonaguro FM
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29385037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiopep-2 and activatable cell penetrating peptide dual modified nanoparticles for enhanced tumor targeting and penetrating.
    Mei L; Zhang Q; Yang Y; He Q; Gao H
    Int J Pharm; 2014 Oct; 474(1-2):95-102. PubMed ID: 25138251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery.
    Gao H; Zhang S; Cao S; Yang Z; Pang Z; Jiang X
    Mol Pharm; 2014 Aug; 11(8):2755-63. PubMed ID: 24983928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the importance of electrostatic interactions between cell penetrating peptides and membranes: a pathway toward tumor cell selectivity?
    Jobin ML; Alves ID
    Biochimie; 2014 Dec; 107 Pt A():154-9. PubMed ID: 25107405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane Crossing and Membranotropic Activity of Cell-Penetrating Peptides: Dangerous Liaisons?
    Walrant A; Cardon S; Burlina F; Sagan S
    Acc Chem Res; 2017 Dec; 50(12):2968-2975. PubMed ID: 29172443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent in vivo advances in cell-penetrating peptide-assisted drug delivery.
    Kurrikoff K; Gestin M; Langel Ü
    Expert Opin Drug Deliv; 2016; 13(3):373-87. PubMed ID: 26634750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The development of cell-penetrating peptides in drug delivery system].
    Fan B; Jin MJ; Huang W; Wang QM; Gao ZG
    Yao Xue Xue Bao; 2016 Feb; 51(2):264-71. PubMed ID: 29856580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.
    Li H; Tsui TY; Ma W
    Int J Mol Sci; 2015 Aug; 16(8):19518-36. PubMed ID: 26295227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-penetrating peptides, electroporation and drug delivery.
    Cahill K
    IET Syst Biol; 2010 Nov; 4(6):367-78. PubMed ID: 21073236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-Activatable Cell-Penetrating Peptides through a Minimal Side Chain Modification.
    Bode SA; Hansen MB; Oerlemans RA; van Hest JC; Löwik DW
    Bioconjug Chem; 2015 May; 26(5):850-6. PubMed ID: 25915685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Primary Mechanism of Cellular Internalization for a Short Cell- Penetrating Peptide as a Nano-Scale Delivery System.
    Liu BR; Huang YW; Korivi M; Lo S-Y; Aronstam RS; Lee H-J
    Curr Pharm Biotechnol; 2017; 18(7):569-584. PubMed ID: 28828981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.